SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-003408
Filing Date
2019-01-11
Accepted
2019-01-11 16:11:30
Documents
2
Period of Report
2019-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1608
2 POA DOCUMENT poa.txt EX-24.3_826385 2890
  Complete submission text file 0001209191-19-003408.txt   5795
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 800 BOYLSTON STREET BOSTON MA 02199
Business Address
Mallon Mark (Reporting) CIK: 0001763533 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34620 | Film No.: 19522452